Type 2 Diabetic Mellitus Is a Risk Factor for Nasopharyngeal Carcinoma: A 1:2 Matched Case–Control Study

Por Peng, Xing-Si, Xie, Guo-Feng, Qiu, Wen-Ze, Tian, Yun-Hong, Zhang, Wei-Jun, Cao, Ka-Jia
Publicado no PLoS One (2016)

High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma

Por Xie, Guo-feng, Zhao, Luo-dan, Chen, Qiang, Tang, Dong-xiao, Chen, Qiong-yu, Lu, Hong-fei, Cai, Jia-rong, Chen, Zheng
Publicado no Drug Des Devel Ther (2020)

Erlotinib: An enhancer of radiation therapy in nasopharyngeal carcinoma

Por ZHANG, HUAN-HUAN, YUAN, TAI-ZE, LI, JIAN, LIANG, YIN, HUANG, LAI-JI, YE, JIA-CAI, ZHENG, RONG-HUI, XIE, GUO-FENG, ZHANG, XIU-PING
Publicado em 2013

Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system

Por Shen, Lu-Jun, Wang, Si-Yang, Xie, Guo-Feng, Zeng, Qi, Chen, Chen, Dong, An-Nan, Huang, Zhi-Mei, Pan, Chang-Chuan, Xia, Yun-Fei, Wu, Pei-Hong
Publicado no Chin J Cancer (2015)

Interfering Expression of Chimeric Transcript SEPT7P2-PSPH Promotes Cell Proliferation in Patients with Nasopharyngeal Carcinoma

Por Wang, Jing, Xie, Guo-Feng, He, Yuan, Deng, Ling, Long, Ya-Kang, Yang, Xin-Hua, Ma, Jiang-Jun, Gong, Rui, Cen, Wen-Jian, Ye, Zu-Lu, Zeng, Yi-Xin, Wang, Hai-Yun, Shao, Jian-Yong
Publicado no J Oncol (2019)